Q1 2010

Filed Apr 30, 2010 · 10-Q · 30 days after period end · 0001013596-10-000047

Q1 2010 · 10-Q

Revenue

$0.00

no prior Q1 2009 on file

Net Income

-$1.29M

no prior Q1 2009 on file

EPS, diluted—

Operating Cash Flow-$1,284,106—

Same quarter

no prior Q1 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Mar 31, 2010 · filed Apr 30, 2010 · 30 d after period end

Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR